12 Tips for Conversational Content As Donald M. Murray once said, “Effective writing should be conversational.” That said, let’s talk. But first, please remember that what follows are tips, not rules. Use them as...
Reputatie marketing SIRE-voorzitter Marc Oosterhout, in het dagelijks leven directeur van reclamebureau N=5, voorspelt in de podcast OnBrandScan dat marketing steeds ondergeschikter raakt aan communicatie en reputatie...
Heat Up Your Content Marketing Game During the Summer Lull: 5 Things To Do People should take vacations. It’s a healthy thing to do. Of course, doing so often disrupts the regular work of the content marketers left...
Merck, known as MSD outside the United States and Canada, announced the first presentation of data from the phase 3 DRIVE─SHIFT trial evaluating a switch of medication to Delstrigo, a once─daily fixed─dose...
Hilversum, 15 February 2019 Reboocon has won the AXON Innovation for Health Award 2019 for the best start-up pitch at the sixth edition of Innovation for Health and the third edition of Global Investor Forum...
Het zelf bereiden van weesgeneesmiddelen door apothekers biedt kansen voor goedkopere alternatieven voor dure geneesmiddelen. Dat stelt de Autoriteit Consument & Markt, die enkele onderzoeken is gestart naar de hoge...
Merck, a leading science and technology company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion to update
Disease-associated mutations
During the past years, artificial intelligence (AI) — the capability of a machine to mimic human behavior — has become a key player in high-techs like drug development projects.
Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its other therapy Tamiflu (oseltamivir) in the reduction of the duration of the symptoms...
COVID-19 vaccine
A leading COVID-19 vaccine candidate, developed at Beth Israel Deaconess Medical Center, creates the groundwork for a newly launched COVID-19 vaccine clinical trial.
We gebruiken cookies om ervoor te zorgen dat onze website zo soepel mogelijk draait. Als u doorgaat met het gebruiken van de website, gaan we er vanuit dat u ermee instemt.